BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 21408206)

  • 1. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Huang C; Zhou H; Tong J; Chen H; Liu YJ; Wang D; Wei X; Xia XG
    PLoS Genet; 2011 Mar; 7(3):e1002011. PubMed ID: 21408206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats.
    Huang C; Tong J; Bi F; Wu Q; Huang B; Zhou H; Xia XG
    Hum Mol Genet; 2012 Nov; 21(21):4602-14. PubMed ID: 22833456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS.
    Vazquez-Sanchez S; Tilkin B; Gasset-Rosa F; Zhang S; Piol D; McAlonis-Downes M; Artates J; Govea-Perez N; Verresen Y; Guo L; Cleveland DW; Shorter J; Da Cruz S
    Mol Neurodegener; 2024 Jun; 19(1):46. PubMed ID: 38862967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic Homeostasis Disruption in a Novel Frontotemporal Dementia Mouse Model Expressing Cytoplasmic Fused in Sarcoma.
    Shiihashi G; Ito D; Arai I; Kobayashi Y; Hayashi K; Otsuka S; Nakajima K; Yuzaki M; Itohara S; Suzuki N
    EBioMedicine; 2017 Oct; 24():102-115. PubMed ID: 28928015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
    Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
    J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
    Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
    Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.
    López-Erauskin J; Tadokoro T; Baughn MW; Myers B; McAlonis-Downes M; Chillon-Marinas C; Asiaban JN; Artates J; Bui AT; Vetto AP; Lee SK; Le AV; Sun Y; Jambeau M; Boubaker J; Swing D; Qiu J; Hicks GG; Ouyang Z; Fu XD; Tessarollo L; Ling SC; Parone PA; Shaw CE; Marsala M; Lagier-Tourenne C; Cleveland DW; Da Cruz S
    Neuron; 2018 Nov; 100(4):816-830.e7. PubMed ID: 30344044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
    Nolan M; Talbot K; Ansorge O
    Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons.
    Ryu HH; Jun MH; Min KJ; Jang DJ; Lee YS; Kim HK; Lee JA
    Neurobiol Aging; 2014 Dec; 35(12):2822-2831. PubMed ID: 25216585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS/FTLD-Linked Mutations in FUS Glycine Residues Cause Accelerated Gelation and Reduced Interactions with Wild-Type FUS.
    Rhine K; Makurath MA; Liu J; Skanchy S; Lopez C; Catalan KF; Ma Y; Fare CM; Shorter J; Ha T; Chemla YR; Myong S
    Mol Cell; 2020 Nov; 80(4):666-681.e8. PubMed ID: 33159856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and behavioural abnormalities in the FUS-tg mice mimic frontotemporal lobar degeneration: Effects of old and new anti-inflammatory therapies.
    de Munter J; Babaevskaya D; Wolters EC; Pavlov D; Lysikova E; V Kalueff A; Gorlova A; Oplatchikova M; Pomytkin IA; Proshin A; Umriukhin A; Lesch KP; Strekalova T
    J Cell Mol Med; 2020 Sep; 24(17):10251-10257. PubMed ID: 32667139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of basophilic inclusions and FUS-immunoreactive neuronal and glial inclusions in a case of familial amyotrophic lateral sclerosis.
    Kobayashi Z; Tsuchiya K; Arai T; Aoki M; Hasegawa M; Ishizu H; Akiyama H; Mizusawa H
    J Neurol Sci; 2010 Jun; 293(1-2):6-11. PubMed ID: 20409561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
    Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR
    Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural impairments in mice of a novel FUS transgenic line recapitulate features of frontotemporal lobar degeneration.
    Lysikova EA; Kukharsky MS; Chaprov KD; Vasilieva NA; Roman AY; Ovchinnikov RK; Deykin AV; Ninkina N; Buchman VL
    Genes Brain Behav; 2019 Nov; 18(8):e12607. PubMed ID: 31437340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.
    Mackenzie IR; Ansorge O; Strong M; Bilbao J; Zinman L; Ang LC; Baker M; Stewart H; Eisen A; Rademakers R; Neumann M
    Acta Neuropathol; 2011 Jul; 122(1):87-98. PubMed ID: 21604077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.
    Wang T; Jiang X; Chen G; Xu J
    Neurobiol Aging; 2015 Jan; 36(1):527-35. PubMed ID: 25192599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.